info@seagull-health.com
SeagullHealth
search
Etrasimod(Velsipity)
Reminder: The outer packaging is for reference only, please purchase and use under the guidance of a pharmacist. For read by medical and pharmaceutical professionals only.
Velsipity(Etrasimod) Instructions:Uses,Dosage, Side Effects
VELSIPITY contains the active ingredient etrasimod, which functions as a sphingosine 1-phosphate (S1P) receptor modulator. It is supplied as 2 mg film-coated tablets for oral administration once daily. The medication works by modulating the immune system, specifically by reducing the migration of lymphocytes from lymphoid tissues into the bloodstream and inflamed intestinal areas, thereby helping to control the inflammation associated with ulcerative colitis.
To reduce the risk of myocardial infarction and coronary revascularization in adults with established cardiovascular disease (CVD) or at high risk for a CVD event who are unable to take recommended statin therapy.
As an adjunct to diet, alone or combined with other LDL-C-lowering therapies, to reduce LDL-C in adults with primary hyperlipidemia, including heterozygous familial hypercholesterolemia (HeFH).
Recommended dose: 180 mg orally once daily.
May be taken with or without food.
Lipid levels should be assessed within 8–12 weeks after initiation.
- Core products
- Antitumor drugs
- General drug
- Antiviral drugs
- Biological agents
- mailbox：info@lucius.la
